NAYA — Naya Biosciences Income Statement
0.000.00%
Last trade - 00:00- $4.83m
- $7.21m
- $3.02m
Annual income statement for Naya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.48 | 1.04 | 4.16 | 0.822 | 3.02 |
| Cost of Revenue | |||||
| Gross Profit | 1.34 | 0.949 | 4.02 | 0.491 | 1.09 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.27 | 6.55 | 9.22 | 11.4 | 10 |
| Operating Profit | -1.79 | -5.51 | -5.06 | -10.6 | -7.02 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.17 | -8.35 | -6.65 | -10.9 | -8.01 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.17 | -8.35 | -6.65 | -10.9 | -8.03 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.17 | -8.35 | -6.65 | -10.9 | -8.03 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.17 | -8.35 | -6.65 | -10.9 | -8.03 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -8.93 | -30.4 | -12.7 | -17.8 | -5.03 |